Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Buffered 1% vs. Unbuffered 2% Lidocaine in Pediatric Subjects
NCT03562481Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in pain (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Mean Pain Scores Following Injection at 10 minutes, Mean Time to Lower Lip Numbness Following Injection at 30 minutes and 7 more. Started Jul 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03562481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562481.